News
He's Back: Vinay Prasad Returns As FDA CBER Head
Vinay Prasad, MD, MPH, who was appointed to run the FDA's Center for Biologics Evaluation and Research (CBER) in May, then resigned in late July after he was criticized by right-wing influencer Laura Loomer, is now back running CBER, according to multiple media reports.
Vinay K. Prasad, MD, MPH, a controversial hematologist-oncologist who abruptly left his two leadership roles at FDA last ...
Vinay Prasad, M.D., has rejoined the FDA, the latest turn in a monthslong stretch of leadership turnover at the agency. | “At ...
The new FDA vaccine chief, Dr. Vinay Prasad was an outspoken critic of the agency's response to the pandemic, including the former vaccine chief, Dr. Peter Marks.
Dr. Vinay Prasad, an oncologist who previously criticized the FDA and was a fierce critic of COVID-19 vaccine and mask mandates, was appointed in May.
Dr. Vinay Prasad was an outspoken critic of the FDA’s response to the pandemic, including the former vaccine chief, Dr. Peter Marks.
Oncologist Vinay Prasad was named the new vaccine chief by the FDA in May 2025. Here’s what you need to know.
Dr. Vinay Prasad was an outspoken critic of the FDA’s response to the pandemic, including the former vaccine chief, Dr. Peter Marks.
Dr. Vinay Prasad was an outspoken critic of the FDA’s response to the pandemic, including the former vaccine chief, Dr. Peter Marks.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback